{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:44:10Z","timestamp":1792676650712,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,22]],"date-time":"2013-12-22T00:00:00Z","timestamp":1387670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11914-013-0183-y","type":"journal-article","created":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T02:22:00Z","timestamp":1387592520000},"page":"9-16","source":"Crossref","is-referenced-by-count":123,"title":["Impact of Inflammation on the Osteoblast in Rheumatic Diseases"],"prefix":"10.1007","volume":"12","author":[{"given":"Rebecca","family":"Baum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Gravallese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,22]]},"reference":[{"key":"183_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semcdb.2008.07.016","volume":"19","author":"NA Sims","year":"2008","unstructured":"Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol. 2008;19:444\u201351.","journal-title":"Semin Cell Dev Biol"},{"key":"183_CR2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","volume":"45","author":"J Kular","year":"2012","unstructured":"Kular J et al. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012;45:863\u201373.","journal-title":"Clin Biochem"},{"key":"183_CR3","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504\u20138.","journal-title":"Science"},{"key":"183_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys. 2008;473:201\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"183_CR5","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","volume":"17","author":"JM Hayden","year":"1995","unstructured":"Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone. 1995;17:93S\u20138S.","journal-title":"Bone"},{"key":"183_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang Y et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757\u201365.","journal-title":"Nat Med"},{"key":"183_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4419-1050-9_6","volume":"658","author":"TJ Martin","year":"2010","unstructured":"Martin TJ et al. Communication between ephrinB2 and EphB4 within the osteoblast lineage. Adv Exp Med Biol. 2010;658:51\u201360.","journal-title":"Adv Exp Med Biol"},{"key":"183_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","volume":"4","author":"C Zhao","year":"2006","unstructured":"Zhao C et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006;4:111\u201321.","journal-title":"Cell Metab"},{"key":"183_CR9","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","volume":"23","author":"EC Walker","year":"2008","unstructured":"Walker EC et al. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res. 2008;23:2025\u201332.","journal-title":"J Bone Miner Res"},{"key":"183_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"183_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jcb.20420","volume":"95","author":"T Komori","year":"2005","unstructured":"Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem. 2005;95:445\u201353.","journal-title":"J Cell Biochem"},{"key":"183_CR12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jbmr.5650100706","volume":"10","author":"DM Biskobing","year":"1995","unstructured":"Biskobing DM, Fan X, Rubin J. Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res. 1995;10:1025\u201332.","journal-title":"J Bone Miner Res"},{"key":"183_CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","volume":"256","author":"N Takahashi","year":"1999","unstructured":"Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun. 1999;256:449\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"183_CR14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"H Yasuda","year":"1998","unstructured":"Yasuda H et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 1998;139:1329\u201337.","journal-title":"Endocrinology"},{"key":"183_CR15","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","volume":"142","author":"YL Ma","year":"2001","unstructured":"Ma YL et al. Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001;142:4047\u201354.","journal-title":"Endocrinology"},{"key":"183_CR16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","volume":"21","author":"KA Blackwell","year":"2010","unstructured":"Blackwell KA, Raisz LG, Pilbeam CC. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab. 2010;21:294\u2013301.","journal-title":"Trends Endocrinol Metab"},{"key":"183_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ceb.2008.01.009","volume":"20","author":"H Huang","year":"2008","unstructured":"Huang H, He X. Wnt\/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol. 2008;20:119\u201325.","journal-title":"Curr Opin Cell Biol"},{"key":"183_CR18","doi-asserted-by":"crossref","unstructured":"Regard JB, et al. Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol. 2012;4.","DOI":"10.1101\/cshperspect.a007997"},{"key":"183_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","volume":"492","author":"DG Monroe","year":"2012","unstructured":"Monroe DG et al. Update on Wnt signaling in bone cell biology and bone disease. Gene. 2012;492:1\u201318.","journal-title":"Gene"},{"key":"183_CR20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jcb.20599","volume":"96","author":"PV Bodine","year":"2005","unstructured":"Bodine PV et al. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem. 2005;96:1212\u201330.","journal-title":"J Cell Biochem"},{"key":"183_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1359\/jbmr.090719","volume":"25","author":"W Yao","year":"2010","unstructured":"Yao W et al. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res. 2010;25:190\u20139.","journal-title":"J Bone Miner Res"},{"key":"183_CR22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/me.2003-0498","volume":"18","author":"PV Bodine","year":"2004","unstructured":"Bodine PV et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 2004;18:1222\u201337.","journal-title":"Mol Endocrinol"},{"key":"183_CR23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","volume":"113","author":"JJ Pinzone","year":"2009","unstructured":"Pinzone JJ et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood. 2009;113:517\u201325.","journal-title":"Blood"},{"key":"183_CR24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res. 2006;21:934\u201345.","journal-title":"J Bone Miner Res"},{"key":"183_CR25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","volume":"39","author":"J Li","year":"2006","unstructured":"Li J et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone. 2006;39:754\u201366.","journal-title":"Bone"},{"key":"183_CR26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3899\/jrheum.100089","volume":"38","author":"SY Wang","year":"2011","unstructured":"Wang SY et al. Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. J Rheumatol. 2011;38:821\u20137.","journal-title":"J Rheumatol"},{"key":"183_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","volume":"71","author":"GR Heiland","year":"2012","unstructured":"Heiland GR et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:572\u20134.","journal-title":"Ann Rheum Dis"},{"key":"183_CR28","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X et al. Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005;280:19883\u20137.","journal-title":"J Biol Chem"},{"key":"183_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001;10:537\u201343.","journal-title":"Hum Mol Genet"},{"key":"183_CR30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","volume":"28","author":"AH Lierop van","year":"2013","unstructured":"van Lierop AH et al. Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers. J Bone Miner Res. 2013;28:848\u201354.","journal-title":"J Bone Miner Res"},{"key":"183_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","volume":"63","author":"H Hamersma","year":"2003","unstructured":"Hamersma H, Gardner J, Beighton P. The natural history of sclerosteosis. Clin Genet. 2003;63:192\u20137.","journal-title":"Clin Genet"},{"key":"183_CR32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23:860\u20139.","journal-title":"J Bone Miner Res"},{"key":"183_CR33","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003;22:6267\u201376.","journal-title":"EMBO J"},{"key":"183_CR34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11914-011-0089-5","volume":"10","author":"AG Costa","year":"2012","unstructured":"Costa AG, Bilezikian JP. Sclerostin: therapeutic horizons based upon its actions. Curr Osteoporos Rep. 2012;10:64\u201372.","journal-title":"Curr Osteoporos Rep"},{"key":"183_CR35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jbmr.1807","volume":"28","author":"JM Spatz","year":"2013","unstructured":"Spatz JM et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res. 2013;28:865\u201374.","journal-title":"J Bone Miner Res"},{"key":"183_CR36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","volume":"24","author":"X Li","year":"2009","unstructured":"Li X et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009;24:578\u201388.","journal-title":"J Bone Miner Res"},{"key":"183_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D et al. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res. 2011;26:19\u201326.","journal-title":"J Bone Miner Res"},{"key":"183_CR38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","volume":"8","author":"G Chen","year":"2012","unstructured":"Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272\u201388.","journal-title":"Int J Biol Sci"},{"key":"183_CR39","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJ Lories","year":"2005","unstructured":"Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005;115:1571\u20139.","journal-title":"J Clin Invest"},{"key":"183_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.11419","volume":"50","author":"P Li","year":"2004","unstructured":"Li P et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 2004;50:265\u201376.","journal-title":"Arthritis Rheum"},{"key":"183_CR41","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345\u201352.","journal-title":"J Clin Invest"},{"key":"183_CR42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106:1481\u20138.","journal-title":"J Clin Invest"},{"key":"183_CR43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010;233:301\u201312.","journal-title":"Immunol Rev"},{"key":"183_CR44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/oxfordjournals.rheumatology.a031490","volume":"39","author":"DL Scott","year":"2000","unstructured":"Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatology. 2000;39:24\u20139.","journal-title":"Rheumatology"},{"key":"183_CR45","first-page":"943","volume":"152","author":"EM Gravallese","year":"1998","unstructured":"Gravallese EM et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998;152:943\u201351.","journal-title":"Am J Pathol"},{"key":"183_CR46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","volume":"27","author":"M Bromley","year":"1984","unstructured":"Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum. 1984;27:968\u201375.","journal-title":"Arthritis Rheum"},{"key":"183_CR47","first-page":"1154","volume":"25","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y et al. Osteoclast-like cells in murine collagen induced arthritis. J Rheumatol. 1998;25:1154\u201360.","journal-title":"J Rheumatol"},{"key":"183_CR48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","volume":"43","author":"E Romas","year":"2000","unstructured":"Romas E et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum. 2000;43:821\u20136.","journal-title":"Arthritis Rheum"},{"key":"183_CR49","first-page":"751","volume":"13","author":"T Kuratani","year":"1998","unstructured":"Kuratani T et al. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol. 1998;13:751\u20139.","journal-title":"Histol Histopathol"},{"key":"183_CR50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000;43:250\u20138.","journal-title":"Arthritis Rheum"},{"key":"183_CR51","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"AR Pettit","year":"2001","unstructured":"Pettit AR et al. TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol. 2001;159:1689\u201399.","journal-title":"Am J Pathol"},{"key":"183_CR52","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","volume":"110","author":"K Redlich","year":"2002","unstructured":"Redlich K et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest. 2002;110:1419\u201327.","journal-title":"J Clin Invest"},{"key":"183_CR53","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2008.097048","volume":"68","author":"U Moller Dohn","year":"2009","unstructured":"Moller Dohn U et al. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1\u00a0year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis. 2009;68:1585\u201390.","journal-title":"Ann Rheum Dis"},{"key":"183_CR54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/ard.2009.123729","volume":"70","author":"UM Dohn","year":"2011","unstructured":"Dohn UM et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT, and radiography study. Ann Rheum Dis. 2011;70:252\u20138.","journal-title":"Ann Rheum Dis"},{"key":"183_CR55","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/ard.2007.071977","volume":"67","author":"EA Haavardsholm","year":"2008","unstructured":"Haavardsholm EA et al. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow edema predicts erosive progression. Ann Rheum Dis. 2008;67:794\u2013800.","journal-title":"Ann Rheum Dis"},{"key":"183_CR56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/ard.2008.088245","volume":"68","author":"ML Hetland","year":"2009","unstructured":"Hetland ML et al. MRI bone edema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomized controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68:384\u201390.","journal-title":"Ann Rheum Dis"},{"key":"183_CR57","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1074\/jbc.M106339200","volume":"277","author":"L Gilbert","year":"2002","unstructured":"Gilbert L et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2002;277:2695\u2013701.","journal-title":"J Biol Chem"},{"key":"183_CR58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S et al. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest. 2005;115:282\u201390.","journal-title":"J Clin Invest"},{"key":"183_CR59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","volume":"13","author":"RL Jilka","year":"1998","unstructured":"Jilka RL et al. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. 1998;13:793\u2013802.","journal-title":"J Bone Miner Res"},{"key":"183_CR60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jbmr.5650020612","volume":"2","author":"P Stashenko","year":"1987","unstructured":"Stashenko P et al. Interleukin-1 beta is a potent inhibitor of bone formation in vitro. J Bone Miner Res. 1987;2:559\u201365.","journal-title":"J Bone Miner Res"},{"key":"183_CR61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2119\/molmed.2012.00058","volume":"19","author":"NE Hengartner","year":"2013","unstructured":"Hengartner NE et al. IL-1beta inhibits human osteoblast migration. Mol Med. 2013;19:36\u201342.","journal-title":"Mol Med"},{"key":"183_CR62","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/en.2004-1167","volume":"146","author":"XH Liu","year":"2005","unstructured":"Liu XH et al. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-{kappa}B (RANK) ligand\/RANK system. Endocrinology. 2005;146:1991\u20138.","journal-title":"Endocrinology"},{"key":"183_CR63","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","volume":"24","author":"NC Walsh","year":"2009","unstructured":"Walsh NC et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009;24:1572\u201385.","journal-title":"J Bone Miner Res"},{"key":"183_CR64","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.33504","volume":"64","author":"MM Matzelle","year":"2012","unstructured":"Matzelle MM et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum. 2012;64:1540\u201350.","journal-title":"Arthritis Rheum"},{"key":"183_CR65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156\u201363.","journal-title":"Nat Med"},{"key":"183_CR66","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR et al. Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis. 2010;69:2152\u20139.","journal-title":"Ann Rheum Dis"},{"key":"183_CR67","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/annrheumdis-2013-203345","volume":"72","author":"XX Chen","year":"2013","unstructured":"Chen XX et al. Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis. 2013;72:1732\u20136.","journal-title":"Ann Rheum Dis"},{"key":"183_CR68","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2010.148395","volume":"70","author":"S Finzel","year":"2011","unstructured":"Finzel S et al. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis. 2011;70:1587\u201393.","journal-title":"Ann Rheum Dis"},{"key":"183_CR69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2011-201075","volume":"72","author":"S Finzel","year":"2013","unstructured":"Finzel S et al. Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis. 2013;72:396\u2013400.","journal-title":"Ann Rheum Dis"},{"key":"183_CR70","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","volume":"38","author":"RJ Lories","year":"2012","unstructured":"Lories RJ, Schett G. Pathophysiology of new bone formation and ankylosis in spondyloarthritis. Rheum Dis Clin North Am. 2012;38:555\u201367.","journal-title":"Rheum Dis Clin North Am"},{"key":"183_CR71","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.2008.102046","volume":"69","author":"S Uderhardt","year":"2010","unstructured":"Uderhardt S et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010;69:592\u20137.","journal-title":"Ann Rheum Dis"},{"key":"183_CR72","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/ar4096","volume":"14","author":"KR Haynes","year":"2012","unstructured":"Haynes KR et al. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther. 2012;14:R253.","journal-title":"Arthritis Res Ther"},{"key":"183_CR73","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel H et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009;60:3257\u201362.","journal-title":"Arthritis Rheum"},{"key":"183_CR74","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3899\/jrheum.100200","volume":"37","author":"HA Chen","year":"2010","unstructured":"Chen HA et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37:2126\u201332.","journal-title":"J Rheumatol"},{"key":"183_CR75","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","volume":"11","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2\u00a0years. Arthritis Res Ther. 2009;11:R127.","journal-title":"Arthritis Res Ther"},{"key":"183_CR76","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/art.24767","volume":"60","author":"G Schett","year":"2009","unstructured":"Schett G et al. Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. Arthritis Rheum. 2009;60:2644\u201354.","journal-title":"Arthritis Rheum"},{"key":"183_CR77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei Y et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269\u201373.","journal-title":"Clin Rheumatol"},{"key":"183_CR78","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00296-010-1769-7","volume":"32","author":"Z Duan","year":"2012","unstructured":"Duan Z et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int. 2012;32:1209\u201314.","journal-title":"Rheumatol Int"},{"key":"183_CR79","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18:1069\u201376.","journal-title":"Nat Med"},{"key":"183_CR80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2013.06.010","volume":"57","author":"JP Sherlock","year":"2013","unstructured":"Sherlock JP, Buckley CD, Cua DJ. The critical role of interleukin-23 in spondyloarthropathy. Mol Immunol. 2013;57:38\u201343.","journal-title":"Mol Immunol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-013-0183-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-013-0183-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-013-0183-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T03:13:38Z","timestamp":1564974818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-013-0183-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,22]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s11914-013-0183-y","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,22]]}}}